Bausch Health director receives 45,871 RSUs

WECHSLER AMY B reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

WECHSLER AMY B reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. director Amy B. Wechsler received an award of 45,871 restricted share units (RSUs) of common shares. The RSUs have a grant date value of $250,000, will vest immediately before the company’s next Annual Meeting of Shareholders, and will be settled in common shares. Following this grant, Wechsler directly holds 313,585 common shares.

Insider Trade Summary

Grant/Award: 45,871 shares

Grant/Award 1 txn

Insider WECHSLER AMY B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 313,585 shares (Direct)

Footnotes (1)

1. F1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Key Figures

RSUs granted: 45,871 RSUs Grant date value: $250,000 Shares after transaction: 313,585 shares +2 more

5 metrics

RSUs granted 45,871 RSUs Award to non-employee director on third business day after election

Grant date value $250,000 Value of RSU award to non-employee director

Shares after transaction 313,585 shares Total common shares directly held after RSU grant

Transaction code A (Grant, award, or other acquisition) Form 4 non-derivative transaction classification

Transaction date May 22, 2026 Date of RSU award to Amy Wechsler

Key Terms

restricted share units ("RSUs"), non-employee directors, grant date value, vest

4 terms

restricted share units ("RSUs") financial

"Represents the award of restricted share units ("RSUs") granted to non-employee directors"

non-employee directors financial

"RSUs granted to non-employee directors of the Issuer on the third business day"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

grant date value financial

"The RSUs have a grant date value of $250,000, vest on the date"

vest financial

"The RSUs have a grant date value of $250,000, vest on the date immediately preceding"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) director Amy Wechsler report on this Form 4?

Amy Wechsler reported receiving 45,871 restricted share units (RSUs) of Bausch Health common shares. The award is compensation for service as a non-employee director and increases her direct holdings to 313,585 common shares after this grant.

What is the value of the RSU grant to Amy Wechsler at Bausch Health (BHC)?

The RSU grant to Amy Wechsler has a grant date value of $250,000. This value represents the compensation awarded to her as a non-employee director, delivered in the form of restricted share units that will later settle in common shares.

When do Amy Wechsler’s Bausch Health (BHC) RSUs vest?

Amy Wechsler’s RSUs vest on the date immediately preceding Bausch Health’s next Annual Meeting of Shareholders. Once vested, the restricted share units will be settled in the company’s common shares, aligning the award with the upcoming director service period.

How many Bausch Health (BHC) shares does Amy Wechsler hold after this RSU award?

After this RSU award, Amy Wechsler directly holds 313,585 Bausch Health common shares. The Form 4 indicates this total ownership figure following the grant of 45,871 restricted share units, reflecting her updated equity position in the company.

Is Amy Wechsler’s Bausch Health (BHC) RSU grant an open-market purchase?

No, the RSU grant is not an open-market purchase. It is a compensation-related award coded as a grant or award acquisition, provided to Amy Wechsler as a non-employee director, with no cash price paid per share in the reported transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 07:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WECHSLER AMY B

(Last) (First) (Middle)

400 SOMERSET CORPORATE BOULEVARD

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/22/2026		A		45,871(1)	A	$0	313,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)